ClinicalTrials.Veeva

Menu

Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation

S

Sohag University

Status

Enrolling

Conditions

Corneal Endothelial Cells

Treatments

Procedure: phakic IOL implantation

Study type

Interventional

Funder types

Other

Identifiers

NCT06849375
Soh-Med--25-1-11MS

Details and patient eligibility

About

our primary aim of the work to assess the effect of phakic IOL implantation on corneal endothelium. we also used the specular microscope to assess the corneal endothelium

Enrollment

30 estimated patients

Sex

All

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Our inclusion criteria include: adults 18-35 years of age, myopia ˃ 6 D , anterior chamber depth (ACD) 2.85 mm or greater , an endothelial cell count of ≥ 2000 cells/mm2 and stable refractive history within 0.5 diopter for 1 year.

Exclusion criteria

  • anterior chamber depth from endothelium < 2.85 mm, previous or current systemic or eye disease , surgery or trauma, pregnancy and nursing.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

group who implant phakic IOL
Other group
Description:
specular microscopy examination to assess the endothelial cells before and after phakic IOL implantation
Treatment:
Procedure: phakic IOL implantation

Trial contacts and locations

1

Loading...

Central trial contact

Alahmady H Alsamman, Professor; Noha M Abdelhameed, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems